Notificação de entrada na fase nacional - PCT
#1.3
09/02/2025
RPI 2852
Application data
Number
112025004412Type
Filing
Publication
PCT
GB2023052319 Examination has not been requested yet. Without that request by 09/08/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:09/08/2026(14 days left)
Latest action published by the INPI: 09/02/2025. We update with every new RPI gazette, published weekly.
Applicants
IMPERIAL COLLEGE INNOVATIONS LIMITED
GB
MYRICX PHARMA LIMITED
GB
Inventors
A. B. (pessoa física)
GB
E. T. (pessoa física)
GB
R. S. (pessoa física)
GB
R. C. (pessoa física)
GB
R. B. (pessoa física)
CH
IPC Classification
Priority claims
EP
22194959.7 · 09/09/2022
EP
22194984.5 · 09/09/2022
GB
2305541.1 · 04/14/2023
GB
2305546.0 · 04/14/2023
Abstract
COMPOSTOS DE IMIDAZO[1,2-A]PIRIDIN CITOTÓXICOS E USO DOS MESMOS EM TERAPIA. A presente invenção refere-se a compostos de fórmula (I) e aspectos relacionados.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
09/02/2025
RPI 2852
#1.1
03/18/2025
RPI 2828
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.